This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Saint Louis University, University of Oklahoma. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021-2023
Title: Keith McCormick Haynes: Innovator in Pharmaceutical Science
Introduction
Keith McCormick Haynes is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that interact with estrogen receptors and bacterial drug permeability.
Latest Patents
Haynes holds 2 patents that showcase his innovative work. His latest patents include "Modulators of the estrogen-related receptor," which describes new estrogen receptor-related orphan receptor (EER) inverse agonist compounds. This patent also details pharmaceutical formulations, methods of synthesis, and their various uses. Another significant patent is "Fluorescent probes for drug permeability in gram negative bacteria," which outlines compounds and methods useful in measuring membrane permeability and efflux transporter activity in bacteria, including multidrug-resistant Gram negative bacteria.
Career Highlights
Throughout his career, Haynes has worked with esteemed institutions such as Saint Louis University and the University of Oklahoma. His research has focused on critical areas that impact drug development and bacterial resistance.
Collaborations
Haynes has collaborated with notable colleagues, including John K. Walker and Thomas Burris, contributing to a rich exchange of ideas and advancements in their respective fields.
Conclusion
Keith McCormick Haynes is a distinguished inventor whose work in pharmaceutical science continues to influence the development of innovative solutions for health challenges. His patents reflect a commitment to advancing medical research and improving drug efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile